Emily C Zabor

18PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersMolecular targetsData models, storage and indexingHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 28, 2026
Propensity Score-Matched External Controls in Rare Disease Trials: A Promising Tool Requiring Rigorous Validation.

|Feb 05, 2026
The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Bridget Adcock, Moaath K Mustafa Ali, Emily C Zabor

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

|Aug 07, 2025
Combining Missing Data Imputation and Internal Validation in Clinical Risk Prediction Models.

Junhui Mi, Rahul D Tendulkar, Sarah M C Sittenfeld

|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

|May 30, 2024
Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Coprescribed Serotonin Receptor Antagonists: A Retrospective Analysis.

Victoria Gutgarts, Supriya Gerardine, Roman A Shingarev

Pageof 3

Frequent Collaborators

2 joint publications

Brian P Hobbs

2 joint publications

Alexander M Kaizer

1 joint publications

Halei C Benefield

1 joint publications

Emma H Allott